Introduction
Langerhans cells (LCs) are antigen-presenting cells of the epidermis that are self-renewing in the steady state 1 but recruited from blood-borne precursors after inflammation. [2] [3] [4] Observations in humans also confirm that LCs can be self-maintained [5] [6] [7] or replaced by bone marrow-derived cells in the context of transplantation and inflammation. [7] [8] [9] [10] The nature of bone marrow-derived LC precursors that repopulate the epidermis after inflammation is incompletely defined. Experiments in mice with clodronate depletion and bead-labeling suggest a monocyte origin but do not completely exclude other precursors. 2 More recent observations in mice lacking LCs as a result of Id2 knockout or conditional ablation show that LC repopulation occurs in 2 waves. 3, 4 The epidermis is initially infiltrated by a short-term precursor with low langerin expression and features in common with monocytes, followed by a long-term precursor that acquires the full phenotype of LCs, including self-renewal capacity. 3, 4 In humans, langerin 1 cells can be made in vitro from monocytes.
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Experiments with CD34 1 progenitors also demonstrate the existence of an LC-differentiation pathway that appears independent of CD14 1 monocytes. 14, 15 A previous report suggested the existence of CD3/7/14/16/19-negative LC precursors in human blood and, although noted to express CD1c, these were incorrectly described as expressing CD1a. 16, 17 Here we show that CD1c 1 blood dendritic cells (DCs) are alternative LC precursors that achieve higher levels of langerin, CD1a, and Birbeck granules than CD14 1 monocytes when exposed to soluble factors known to drive LC differentiation.
Methods
Blood mononuclear cells were obtained from healthy volunteers under local ethical approval. CD14 1 monocytes, CD16 1 monocytes, CD1c 1 DCs, and CD123 1 plasmacytoid DCs were sorted from peripheral blood mononuclear cells (PBMCs). LCs were isolated from epidermal sheets separated from whole-skin keratome sections with dispase (Invitrogen) 1 mg/mL incubated at 37°C for 90 minutes in RPMI 1640 and subsequently digested with collagenase (Worthington Type IV) 1.6 mg/mL incubated for 12 hours at 37°C in RPMI 1640 with 10% fetal bovine serum. Sorting was performed with an ARIA Fusion (Becton Dickinson) using previously described protocols (supplemental Figure 1 , available on the Blood Web site). 18 Ten-thousand cells were cultured in RPMI 1640 with 10% fetal bovine serum or X-Vivo in 100 mL. Supplements were added at the following concentrations: GM-CSF 50 ng/mL, TGFb, 10 ng/mL, and BMP7 200 ng/mL. Cultures were maintained for 3 to 7 days and supplemented with fresh cytokines on day 4. Flow cytometry analysis was performed with an FACS Canto (Becton Dickinson) using appropriate isotype controls. Antibodies were from Becton Dickinson unless stated otherwise (antigen fluorochrome clone): CD1a BV421 HI149, CD1c PeCy7 L161, CD3 FITC SK7, CD11b APC ICRF44, CD11c A700 B-ly6; CD11c APCCy7 Bu15, and CD14 BV650 M5E2 (all from Biolegend); CD14 ECD RMO52 (Beckman Coulter); CD16 APCCy7 3G8; CD19 FITC 4G7; CD34 FITC 8G12; CD20 FITC L27; CD56 FITC NCAM16.2; CD83 FITC HB15e; CD123 PerCPCY5.5 7G3; CD207 PE DCGM4 (Beckman Coulter); E-Cadherin APC 67A4 (Biolegend); EpCAM APC EBA-1; and HLA-DR V500 G46-6.
Cells were fixed for electron microscopy (EM) according to standard protocols in 2% glutaraldehyde, and then pelleted, dehydrated, and fixed in resin (reagents from TAAB Laboratory, Aldermarston, UK). Ultrathin There is an Inside Blood Commentary on this article in this issue.
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sections were cut with a diamond knife RMC MT-XL ultramicrotome and examined with a Philips CM 100 Compustage (FEI) Transmission Electron Microscope. Images were collected with an AMT CCD camera (Deben).
Results and discussion
DC and monocyte fractions of human PBMCs were cultured in conditions that induce langerin in progenitor cells, including BMP7. [19] [20] [21] [22] [23] This induced a rapid upregulation of langerin and CD1a dual expression by CD1c
1 DCs, peaking within 3 days ( Figure 1A-B Figure 1C ). Induction of a CD1a 1 langerin high population was restricted to CD1c DCs treated with TGFb, BMP7, or both ( Figure 1D ). No significant synergy was observed between TGFb and BMP7, in contrast to recent results obtained with TGFb and thymic stromal lymphopoietin (TSLP). 24 No langerin induction was seen in medium with serum alone, but serum-free medium with supplements also failed to induce any expression, in contrast to results obtained with CD34 1 progenitor cells. 20, 23 (Figure 2A-B) . CD1c 1 DCs developed similar cytologic appearance to freshly isolated LCs (supplemental Figure 2) . Extended phenotyping showed induction of EpCAM and E-cadherin, and low expression Figure 3) . It is therefore likely that CD1c 1 DCs contribute significantly to LC development when these preparations are induced to differentiate.
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There are 2 limitations to this study. First, other conditions not tested here, such as Notch ligation, may be capable of inducing higher langerin in CD14 1 monocytes. 12, 13 Birbeck granule formation was reported in monocytes exposed to Delta-1, 12 although with Jagged, langerin expression did not exceed that observed with GM-CSF and TGFb. 13 Second, although the Birbeck granule is the ultrastructural hallmark of LC phenotype in vivo, the derivation of Birbeck granule-containing cells in vitro does not prove a precursor-progeny relationship. The expression of EpCAM and E-cadherin and low level of CD11b are consistent with an LC phenotype, but further expression profiling and functional studies would be required to evaluate fully the proximity of derived cells to primary LCs. It would be of interest to determine whether a similarly high capacity to crosspresent antigen is found in CD1c
1 DC-derived LC-like cells, as shown by those obtained from CD34 1 progenitors. 21, 22 However, it has been reported that crosspresentation is not as marked in freshly isolated primary LCs 18 and may not be discriminatory for LC differentiation, because it is easily induced in CD1c
1 DCs under other conditions. 25 Although the cultures contained serum, as in other recent publications describing DC differentiation, 24, 26 the factors GM-CSF, TGFb, and BMP7 are expressed by epithelial tissues under physiologic conditions. 23 Previous experiments on CD34 Finally, these data explain the puzzling claim that there are CD1a
1 "LC precursors" in human blood. 16 Blood DCs were reported to express CD1a as a result of incorrect assignment of clone BB5 as a CD1a-specific antibody. It is now known that BB5 recognizes CD1b/c and not CD1a. 17 The nonmonocyte cells in human blood that give rise to LCs in response to TGFb and BMP7 in vitro are now clearly shown to be CD1c 1 DCs.
